These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 23691067

  • 1. Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.
    Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, König P, Neyer U, Pilz S, Wanner C, Kronenberg F, MMKD Study Group.
    PLoS One; 2013; 8(5):e63560. PubMed ID: 23691067
    [Abstract] [Full Text] [Related]

  • 2. Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohort.
    Maas R, Mieth M, Titze SI, Hübner S, Fromm MF, Kielstein JT, Schmid M, Köttgen A, Kronenberg F, Krane V, Hausknecht B, Eckardt KU, Schneider MP.
    Nephrol Dial Transplant; 2020 Jul 01; 35(7):1187-1195. PubMed ID: 30476224
    [Abstract] [Full Text] [Related]

  • 3. Homoarginine, cardiovascular risk, and mortality.
    März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C.
    Circulation; 2010 Sep 07; 122(10):967-75. PubMed ID: 20733103
    [Abstract] [Full Text] [Related]

  • 4. Homoarginine, kidney function and cardiovascular mortality risk.
    Tomaschitz A, Meinitzer A, Pilz S, Rus-Machan J, Genser B, Drechsler C, Grammer T, Krane V, Ritz E, Kleber ME, Pieske B, Kraigher-Krainer E, Fahrleitner-Pammer A, Wanner C, Boehm BO, März W.
    Nephrol Dial Transplant; 2014 Mar 07; 29(3):663-71. PubMed ID: 24398889
    [Abstract] [Full Text] [Related]

  • 5. Serum concentrations of L-arginine and L-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC Study.
    Vogl L, Pohlhammer J, Meinitzer A, Rantner B, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kronenberg F, Kollerits B.
    Atherosclerosis; 2015 Apr 07; 239(2):607-14. PubMed ID: 25746168
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
    Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H.
    Transplantation; 2015 Jul 07; 99(7):1470-6. PubMed ID: 25675199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study.
    Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Böger SM, Haller H, Ritz E.
    J Am Soc Nephrol; 2005 Aug 07; 16(8):2456-61. PubMed ID: 15930091
    [Abstract] [Full Text] [Related]

  • 12. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease.
    Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D.
    J Am Soc Nephrol; 2002 Jan 07; 13(1):170-176. PubMed ID: 11752034
    [Abstract] [Full Text] [Related]

  • 13. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R, Ramezani A, Claes K, Augustijns P, Kuypers D, Barrows IR, Muralidharan J, Evenepoel P, Meijers B, Raj DS.
    Clin J Am Soc Nephrol; 2015 Sep 04; 10(9):1525-33. PubMed ID: 26153127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes.
    Imbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Del Giudice A, Ravani P.
    Am J Kidney Dis; 2007 Jun 04; 49(6):753-62. PubMed ID: 17533018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?
    Donadio C, Ardini M, Lucchesi A, Donadio E, Cantor T.
    Clin Nephrol; 2007 Mar 04; 67(3):131-9. PubMed ID: 17390737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.